0000905718-21-001237.txt : 20210928 0000905718-21-001237.hdr.sgml : 20210928 20210928130816 ACCESSION NUMBER: 0000905718-21-001237 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210928 DATE AS OF CHANGE: 20210928 EFFECTIVENESS DATE: 20210928 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Cingulate Inc. CENTRAL INDEX KEY: 0001862150 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 863825535 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-414866 FILM NUMBER: 211285611 BUSINESS ADDRESS: STREET 1: 1901 W. 47TH PLACE CITY: KANSAS CITY STATE: KS ZIP: 66205 BUSINESS PHONE: (913) 942-2300 MAIL ADDRESS: STREET 1: 1901 W. 47TH PLACE CITY: KANSAS CITY STATE: KS ZIP: 66205 D 1 primary_doc.xml X0708 D LIVE 0001862150 Cingulate Inc. 1901 W. 47TH PLACE KANSAS CITY KS KANSAS 66205 (913) 942-2300 DELAWARE None None Corporation true 2021 Gregg Givens 1901 W. 47th Place Kansas City KS KANSAS 66205 Director Curt Medeiros 1901 W. 47th Place Kansas City KS KANSAS 66205 Director Shane J Schaffer 1901 W. 47th Place Kansas City KS KANSAS 66205 Executive Officer Director Patrick Gallagher 1901 W. 47th Place Kansas City KS KANSAS 66205 Director Jeff Hargroves 1901 W. 47th Place Kansas City KS KANSAS 66205 Director Peter J Werth 1901 W. 47th Place Kansas City KS KANSAS 66205 Director Jeff Conroy 1901 W. 47th Place Kansas City KS KANSAS 66205 Director Pharmaceuticals Decline to Disclose 06b false true false true true 0 220000000 0 220000000 Implied per share value. Stock exchange in connection with restructuring merger. true 0 0 0 0 false Cingulate Inc. /s/ Craig S. Gilagallon Craig S. Gilgallon General Counsel 2021-09-28